Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy.

Front Med (Lausanne)

Department of Biological Sciences, University of Lethbridge, Lethbridge, AB, Canada.

Published: September 2021

Colorectal cancer is a major public health problem. Unfortunately, currently, no effective curative option exists for this type of malignancy. The most promising cancer treatment nowadays is immunotherapy which is also called biological or targeted therapy. This type of therapy boosts the patient's immune system ability to fight the malignant tumor. However, cancer cells may become resistant to immunotherapy and escape immune surveillance by obtaining genetic alterations. Therefore, new treatment strategies are required. In the recent decade, several reports suggest the effectiveness of cannabinoids and extracts for inhibiting cancer proliferation and , including intestinal malignancies. Cannabinoids were shown to modulate the pathways involved in cell proliferation, angiogenesis, programmed cell death and metastasis. Because of that, they are proposed as adjunct therapy for many malignancies. By far less information exists on the potential of the use of cannabis in combination with immunotherapy. Here, we explore the possibility of the use of cannabinoids for modulation of immunotherapy of colon cancer and discuss possible advantages and limitations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497796PMC
http://dx.doi.org/10.3389/fmed.2021.713153DOI Listing

Publication Analysis

Top Keywords

colorectal cancer
8
cancer
6
immunotherapy
5
cannabinoids
4
cannabinoids medical
4
medical cannabis
4
cannabis colorectal
4
cancer immunotherapy
4
immunotherapy colorectal
4
cancer major
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!